Charles Q. Huang

Co-founder, COO

Charles Huang is currently Co-founder and Chief Operating Officer of ABM Therapeutics Inc.  His roles include the corporate strategy, finance, business development, and external collaboration.

 

Before co-founding ABM, Charles was President and Principal Partner for Amnova Corporation, and VP and Advisor of Strategic Business Development Asia at the Torrey Pines Investment.  Charles served as VP of Global BD of Sundia from 2008 to 2014. Prior to Sundia, Charles worked for 15 years as medicinal chemist at Neurocrine Bioscience Inc (NBI), Johnson & Johnson and Amylin, including CRO project management and emerging market BD for advanced clinic candidate.  He is co-author for 22 publications, 10 presentations and 12 US patents.

 

Charles is a life-time member of the prestigious BayHelix group. graduated with BS in Polymer Chemistry from University of Science and Technology of China (USTC) in 1989 and obtained his MS in organic chemistry at California State University at Northridge in 1992.